UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year

The Lancet. Haematology, 2021-07, Vol.8 (7), p.e524-e533

2021

Volltextzugriff (PDF)

Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial

PLoS medicine, 2020-06, Vol.17 (6), p.e1003142-e1003142

2020

Volltextzugriff (PDF)

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb Ischemia: The Randomized, Double-Blind, Placebo-Controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) Trial

Circulation (New York, N.Y.), 2015-03, Vol.131 (10), p.851-860

2015

Volltextzugriff (PDF)

Pathophysiology of hemophilic arthropathy and potential targets for therapy

Pharmacological research, 2017-01, Vol.115, p.192-199

2017

Volltextzugriff (PDF)

Toward Flow Cytometry Based Platelet Function Diagnostics

Seminars in thrombosis and hemostasis, 2018-04, Vol.44 (3), p.197-205

2018

Volltextzugriff (PDF)

Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies

HemaSphere, 2024-01, Vol.8 (1), p.e37-n/a

Schutgens, Roger E. G.

2024

Volltextzugriff (PDF)

DOAC in COVID‐19: Yes or No?

HemaSphere, 2021-01, Vol.5 (1), p.e526-n/a

Schutgens, Roger E.

2021

Volltextzugriff (PDF)

Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded

Haematologica (Roma), 2012-10, Vol.97 (10), p.1507-1513

2012

Volltextzugriff (PDF)

Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

Blood, 2021-05, Vol.137 (21), p.2997-3001

2021

Volltextzugriff (PDF)

Aptamers Targeting Von Willebrand Factor: What and Why?

HemaSphere, 2023-02, Vol.7 (2), p.e830-n/a

Schutgens, Roger E. G.

2023

Volltextzugriff (PDF)

How I treat age-related morbidities in elderly persons with hemophilia

Blood, 2009-12, Vol.114 (26), p.5256-5263

2009

Volltextzugriff (PDF)

No immunological changes after factor VIII product switch: An in depth analysis in haemophilia A patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-07, Vol.29 (4), p.1039-1048

2023

Volltextzugriff (PDF)

Terminal half‐life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database

Journal of thrombosis and haemostasis, 2021-08, Vol.19 (8), p.1896-1906

2021

Volltextzugriff (PDF)

IL-1β, in contrast to TNFα, is pivotal in blood-induced cartilage damage and is a potential target for therapy

Blood, 2015-11, Vol.126 (19), p.2239-2246

2015

Volltextzugriff (PDF)

Gene Therapy for Hemophilia A: How Long Will It Last?

HemaSphere, 2022-06, Vol.6 (6), p.e720-n/a

Schutgens, Roger E. G.

2022

Volltextzugriff (PDF)

First‐line Therapy for Immune Thrombocytopenia: Time for Change

HemaSphere, 2022-10, Vol.6 (10), p.e783-n/a

Schutgens, Roger E. G.

2022

Volltextzugriff (PDF)

Aspirin as Thromboprophylaxis in Orthopedic Surgery: A Matter of Perspective

HemaSphere, 2023-08, Vol.7 (8), p.e933-n/a

2023

Volltextzugriff (PDF)

Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial

Trials, 2015-09, Vol.16 (1), p.393, Article 393

2015

Volltextzugriff (PDF)

Pharmacokinetics and Associated Efficacy of Emicizumab in Humans: A Systematic Review

Clinical pharmacokinetics, 2021-11, Vol.60 (11), p.1395-1406

2021

Volltextzugriff (PDF)

Magnetic resonance imaging evidence for subclinical joint bleeding in a Dutch population of people with severe hemophilia on prophylaxis

Journal of thrombosis and haemostasis, 2023-05, Vol.21 (5), p.1156-1163

2023

Volltextzugriff (PDF)

Coordinating physiotherapy care for persons with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-11, Vol.27 (6), p.1051-1061

2021

Volltextzugriff (PDF)

New concepts for anticoagulant therapy in persons with hemophilia

Blood, 2016-11, Vol.128 (20), p.2471-2474

2016

Volltextzugriff (PDF)

Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions

Cochrane database of systematic reviews, 2015-12 (12), p.CD011385-CD011385

2015

Volltextzugriff (PDF)

Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients

American journal of hematology, 2019-05, Vol.94 (5), p.575-584

2019

Volltextzugriff (PDF)

Toward responsible clinical n-of-1 strategies for rare diseases

Drug discovery today, 2023-10, Vol.28 (10), p.103688-103688, Article 103688

2023

Volltextzugriff (PDF)

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(197)

Publikationsform

Sprache

Englisch
(236)
Niederländisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year

Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb Ischemia: The Randomized, Double-Blind, Placebo-Controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) Trial

Pathophysiology of hemophilic arthropathy and potential targets for therapy

Toward Flow Cytometry Based Platelet Function Diagnostics

Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies

DOAC in COVID‐19: Yes or No?

Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded

Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

Aptamers Targeting Von Willebrand Factor: What and Why?

How I treat age-related morbidities in elderly persons with hemophilia

No immunological changes after factor VIII product switch: An in depth analysis in haemophilia A patients

Terminal half‐life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database

IL-1β, in contrast to TNFα, is pivotal in blood-induced cartilage damage and is a potential target for therapy

Gene Therapy for Hemophilia A: How Long Will It Last?

First‐line Therapy for Immune Thrombocytopenia: Time for Change

Aspirin as Thromboprophylaxis in Orthopedic Surgery: A Matter of Perspective

Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial

Pharmacokinetics and Associated Efficacy of Emicizumab in Humans: A Systematic Review

Magnetic resonance imaging evidence for subclinical joint bleeding in a Dutch population of people with severe hemophilia on prophylaxis

Coordinating physiotherapy care for persons with haemophilia

New concepts for anticoagulant therapy in persons with hemophilia

Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions

Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients

Toward responsible clinical n-of-1 strategies for rare diseases

Suchergebnisse filtern